Sleep apnea affects as many as 80 million in the U.S. alone. Now Apnimed, the $400 million company behind the first ever pill to treat it, is preparing to file for FDA approval. https://t.co/Vjs2cq7XdB (Photo: Albie Colantonio for Forbes) https://t.co/8R3i6uxdK1 ...